T0	Outcomes 34 74	senescent T-lymphocyte subsets in blood.
T1	Outcomes 269 329	phenotypic characteristics of T-lymphocyte subsets in blood.
T2	Outcomes 796 965	increased the mobilization of CD3, CD4, CD8, or CD8(bright) lymphocytes expressing activated (CD11a) or senescent (KLRG1) molecules into the peripheral blood compartment
T3	Outcomes 988 1040	up-regulated co-stimulatory molecule CD28 expression
T4	Outcomes 1064 1130	depressed KLRG1 level on CD3, CD4, CD8, or CD8(bright) lymphocytes
T5	Outcomes 1196 1260	increased interferon-γ (IFN-γ) level and unchanged interleukin-4
T6	Outcomes 1276 1336	as, decreased myeloperoxidase (MPO) and interleukin-6 levels
T7	Outcomes 1395 1486	exercise-induced mobilizations of various T-lymphocyte subsets and productions of cytokines
T8	Outcomes 1597 1676	intervention reduced senescent T-lymphocyte subsets with increasing IFN-γ level
T9	Outcomes 1707 1778	accompanied by depressed oxidative stress and pro-inflammatory cytokine
T10	Outcomes 1858 1884	regimen to minimize immune
T11	Outcomes 1897 1922	by retarding T-lymphocyte